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Low rectal cancerAbstract Background: The improvement in surgical techniques alongside neoadjuvant chemora-
diation enabled more patients with low rectal cancer to have sphincter preservation.
Study aim: To compare the oncologic and functional outcome in patients with locally advanced
low rectal cancer treated by neoadjuvant chemoradiation followed by sphincter saving resection
(SSR) against those who underwent abdomino-perineal resection (APR).
Patients and methods: A total of 111 patients with low rectal cancer were included in the study.
Sixty-one consented patients who prospectively underwent SSR, from Jan 2008 to Jan 2013, and
a retrospective group, formed of 50 patients, selected from cases seen at NCI, with comparable
demographic, clinical and pathologic criteria, who underwent APR from Jan 2003 to Jan 2008.
All lesions were <5 cm from anal verge. All 111 patients received preoperative chemoradiation
and total mesorectal excision.
Results: All tumors were located at a median of 3.6 cm (range 2.5–4.5 cm) for the SSR group, and
3.5 cm (range 2.5–4.6 cm) for the APR group, from the anal verge. The median follow-up was
34 months (range 1–60 months) for both groups. The difference in disease recurrence and OS
between the APR and SSR groups were both statistically insigniﬁcant.
Conclusion: In low rectal cancer, the sphincter preservation appears to have nearly the same
oncologic outcome compared to APR, this might be attributed to the small sample size and short
follow up period. However, patients with sphincter preservation have certainly demonstrated an
indisputable better functional outcome, in terms of stoma avoidance and adequate continence.
ª 2014 Production and hosting by Elsevier B.V. on behalf of National Cancer Institute, Cairo University.
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The standard surgical treatment for rectal adenocarcinoma
located up to 5 cm from the anal verge is abdominoperineal
resection (APR) [1]. Nowadays, the improvement in functional
outcome is a third goal, after overall survival and disease-free
survival [2], as the functional result and quality of life of
patients who suffer from colorectal cancer has become part
of the primary treatment and is being assessed together with
the oncologic outcomes. Engel et al. [3] reported that patients
with stoma have low self-esteem, altered body image and
decreased sexual and physical activity when compared to the
others. Thereby, sphincter-preserving operations for lower
rectal cancer are becoming more common with the introduc-
tion of improved surgical techniques, the use of preoperative
concurrent chemoradiation therapy (CCRT), and the realiza-
tion that a distal resection margin of 1 cm is sufﬁcient to
achieve curative resection in most patients [4–7]. However, lim-
itations to the application of SSR are mainly the result of tech-
nical difﬁculties, in addition to oncological considerations: the
proximity to, or direct involvement of, the anal sphincter or
the levator ani. Accordingly, all the advances, a subset of these
patients continues to require abdominoperineal resection [2].
The aim of this study was to explore the possible advantages
of the sphincter saving resection (SSR) in patients with locally
advanced low rectal cancer treated by neoadjuvant chemoradi-
ation, over the standard abdomino-perineal resection (APR),
in terms of postoperative continence, overall survival and dis-
ease recurrence.Patients and methods
A total of 111 patients with low rectal cancer were included in
the study. Sixty-one consented patients prospectively under-
went sphincter saving resections (SSR). The sample was
selected in such a way to detect a medium effect size, with
an 80% power and 5% error from January 2008 to January
2013. A retrospective group, of 50 patients, was selected from
cases seen at NCI with comparable demographic, clinical and
pathologic criteria who underwent APR from January 2003 to
January 2008. Patients preoperative enrollment evaluation
included liver and kidney function tests, complete blood
picture, serum CEA level, digital chest and abdomen erect
plain X-rays, endoscopic transrectal ultrasound (ETRUS),Figure 1 Ultra-low Anterior resection using the double stapling techn
autonomic nerve preservation (PANP).abdominopelvic CT with double contrast, colonoscopy with
biopsy. Tumor staging was done according to the TNM stage.
All patients had low rectal cancer within 5 cm from the anal
verge, had locally advanced stage (IIb–III), and received long
course of neoadjuvant chemo-radiation (50.4 Gy/28 fractions,
and concurrent chemotherapy). Fast track preparation was
adopted for new patients. Patients who were not amenable
to SSR after the neoadjuvant chemo-radiation underwent
abdomoinoperineal and were excluded from the study.
Surgical technique
Different techniques of sphincter preservation were used
depending of the site of the tumor. It is important, here, to
remember that the resection with a 1 cm longitudinal
macroscopic margin should always be the minimum goal in
these resections [1]. The rectum was always mobilized off the
sacrum using sharp dissection along the parietal fascia, ensur-
ing en-bloc resection of the mesorectum (TME), according to
the technique proposed by Heald [8]. Different techniques were
used as follows:
 Low anterior resection (LAR) and colo-anal anastomosis:
For tumors 1 cm, or more, proximal to the dentate line, a
classic low anterior resection took place. The colo-anal
anastomosis was done manually, or using a circular stapler
after resection was done using a straight stapler, and anas-
tomosis was completed by the ‘‘double stapling technique’’
(Fig. 1).
 Transanal resection and pull-through anastomosis:
For tumors within the anal canal, full resection of the inner
sphincter was undertaken with pull-through of the proximal
colon, to be anastomosed at the distal edge of the external
sphincter.
 Intersphincteric resection (ISR):
Three types of ISR were used, namely: total, subtotal, and
partial. When inevitable, due to tumor spread beyond the
dentate line, total ISR was completed by fully excising the
internal sphincter, so that the distal margin of the resection
is at the intersphincteric groove. In few cases, where the dis-
tal edge of the tumor was more than 2 cm far from dentate
line, subtotal ISR was performed, getting the distal resec-
tion margin between the dentate line and the intersphincter-
ic groove. Preferably, when otherwise enough distal surgical
margin existed, distal resection was performed, at or above,ique with linear (A) and circular (B) staplers with TME and pelvic
Table 1 Patients characteristics display
Characteristic SSR (n= 61) APR (n= 50) p-Value
Sphincter saving and abdomino-perineal resections in rectal cancer 21the dentate line, named partial ISR. Dissection was contin-
ued through intersphincteric plane till reaching the abdo-
men dissection level (Fig. 2) [9]. A straight colo-anal
hand-sewn anastomosis was done to all the ISR patients,
and few of the LAR patients.
In all cases, lateral lymph node dissection (LND) and pelvic
autonomic nerve preservation (PANP) were carried out in
persisting T3 patients whom MRI pelvic examination revealed
nodal diameter >5 mm with heterogeneous pattern. Frozen-
section examination was used to conﬁrm the lack of tumor
cells in the distal margin. A de-functioning stoma was done
for all preoperatively irradiated patients and in those with very
low tumors.
Postoperative treatment
Postoperatively, chemotherapy and/or radiotherapy were
offered to all indicated patients. All T3 patients received
neoadjuvant chemoradiation with or without adjuvant chemo-
therapy. Patients were followed up until the end of 2012. For
the ﬁrst 2 years, patients were reviewed every 3 months for
clinical examination, CEA. Abdomino-pelvic US and CXR
were done every 6 months. CT chest, and abdomino-pelvic
MRI with full colonoscopy were carried out on annual basis.
PET-CT was done to investigate any suspicious ﬁndings dur-
ing the regular follow up protocol. The following 3 years,
patients were checked every 6 months then annually thereafter.
Statistical methods
Data management and analysis were performed using Statisti-
cal Package for Social Sciences (SPSS) vs. 17. Comparison
between the age of the two groups was done using the Stu-
dent-t test. Categorical data were compared using Chi-square
test. Overall Survival (OS) time was calculated from the date
of diagnosis to date of death or last follow-up. The recurrence
time was calculated from the date of operation to the date ofFigure 2 The dotted line shows the plane of intersphincteric
resection. IS, internal sphincter; PR, puborectalis muscle; ES,
external sphincter.recurrence, or death. OS and recurrence time were estimated
using the methods of Kaplan and Meier. Differences between
survival curves were assessed for statistical signiﬁcance with
the log-rank test. All p-values are two-sided. P-values < 0.05
were considered signiﬁcant.
Results
In this study all tumors were located at a median of 3.6 cm
(range 2.5–4.5 cm) for the SSR group, and 3.5 cm (range
2.5–4.6 cm) for the APR group, from the anal verge. Patient’s
characteristics are detailed in table 1.
Surgical procedures
All patients received preoperative chemoradiation and total
mesorectal excision. The different surgical procedures under-
taken are detailed in table 2, with the pictures of removed spec-
imen shown in Fig. 3. Most patients with LAR had either
hand-sewn or DST anastomosis; while patients with anorectal
resection had hand-sewn colo-anal pull-through anastomosis.
Only three patients with coincidental familial polyposis had
total proctocolectomy with ileo-anal J-pouch reconstruction.
Oncologic outcome
Circumferential margin (CRM) status, in both groups, and its
impact on outcome are detailed in Table 3.
With a median follow up of 34 months (range 1–
60 months), for each group, there were 7 and 10 local recur-
rences among sphincter preservation and APR patients,
respectively; while local recurrences occurred in a total of 12Sex
Male 44 (72.1%) 36 (72.0%) 0.988
Female 17 (27.9%) 14 (28.0%)
M:F ratio 2.6:1 2.6:1
Age
Mean ± SD 48.4 ± 14.4 48.0 ± 14.6 0.877
TNM stage
IIb 22 (36.1%) 19 (38.0%) 0.834
III 39 (63.9%) 31 (62.0%)
SSR, sphincter saving resections; APR, abdominoperineal resec-
tion; SD, standard deviation.
Table 2 Surgical procedures used
Surgical procedure used No. %
Sphincter saving resection (SSR) 61
Ultra-low anterior resection (LAR) 39 63.9
Inter-sphincteric resection (ISR) 15 24.6
Anorectal resection 4 6.6
Total proctocolectomy 3 4.9
Abdomino-perineal resection (APR) 50
Figure 3 Resected specimen for low rectal tumor with TME: (A) intact specimen; (B) open showing complete tumor response following
neo-adjuvant chemoradiation.
Table 3 CRM involvement impact on outcome.
Outcome CRM Negative CRM Positive p-Value
No. % No. %
Surgery type
SSR (n= 61) 48 78.7 13 21.3 0.134
APR (n= 50) 33 66.0 17 34.0
Outcome
Local recurrence
SSR (n= 61) 2 5
APR (n= 50) 2 8
Intraoperative tumor perforation 3 2.7 8 7.2
CRM, circumferential margin; SSR, sphincter saving resections; APR, abdomino-perineal resection.
Figure 4 Disease recurrence rates for sphincter saving resection
(SSR) and abdomino-perineal resection (APR) cases.
Figure 5 Overall survival for sphincter saving resection (SSR)
and abdomino-perineal resection (APR) cases.
Table 4 Sphincter preserving resections (SSR) and abdomi-






Overall survival (OS) APR 50 6 84.9 0.948
SSR 61 7 85.4
Disease recurrence APR 50 14 33.8 0.107
SSR 61 9 18.0
Functional outcome.
22 W. Gawad et al.patients; 5 in sphincter preservation and 7 in APR patients.
The difference in disease recurrence (Fig. 4) and OS (Fig. 5)
between the APR and SSR groups were both statistically insig-
niﬁcant (p= 0.107, and 0.948, respectively) (see Table 4). Con-
tinence outcome for patients with sphincter preserving
resections (SSR), at 12 months after SSR, and after covering
colostomy closure is presented in Table 5.
Discussion
The oncological and functional outcomes of SSR were
dramatically changed by the recognition of the importance
Table 5 Sphincter preserving resections (SSR) continence
outcome, at 12 months after SSR, and after covering colostomy
closure:
Continence outcome (Kirwan Grading Scale) No (n= 61) %
Perfect 44 72.1
Incontinence with ﬂatus 12 19.7
Accidental feces soiling 0 0.0
Frequent major soiling 5 8.2
Anal incontinence 0 0.0
Sphincter saving and abdomino-perineal resections in rectal cancer 23of circumferential margin involvement. Once it was discovered
that cancer initially spreads laterally into the mesorectum, the
priority of operations for mid and low rectal cancers became
total mesorectal excision (TME) [8]. Fucini et al. [10] reported
that selected patients with very low-lying rectal cancers and
responding to preoperative chemoradiation could still be
treated with an advanced sphincter-sparing procedure instead
of APR with satisfactory oncologic and functional results.
In this study we report 3.6% and 11.7% local recurrences in
CRM-negative and CRM-positive APR cases, respectively,
comparable to the 5% and 14.9–23.8% reported by other
authors [11–13]. The higher rates of one of these studies can
be explained by their longer duration of follow-up reaching
up to 10 years, and the fact that it included all APR cases done
in their institution, not surgically selected ‘‘curative’’ cases.
In this study, the authors also report a CRM-positive in
21.3% of SSR patients with a local recurrence rate of 8.2%,
compared to 5–11% and 2%, respectively, reported by other
authors [14,15]. Since, the latter two studies concentrated on
low rectal tumors and used long-course preoperative radio-
therapy, this difference relates most probably to a learning
curve that affected the ﬁrst cases in our study, leading to a
higher CRM-positive rate and consequently higher recurrence
rates.
We report in this study 11/111 (9.9%) cases, with both
resection techniques, of tumor perforation during dissection,
all of which in cases with anterior located lesions. Though
we restored the integrity of the margins during resection, spec-
imen examination showed 3 (2.7%) cases with CRM-negative
and 8 (7.2%) with CRM-positive specimen, but all of them
developed local recurrences later on. This correlates with a
number of studies that have demonstrated improvements in
local recurrence with a negative CRM (C1–2 mm) [11,12,16–
19].
However, in this study, the 3 year recurrence rate at the
SSR patient group (18.0%), compared to the APR group
(33.8%) was not statistically signiﬁcant (p= 0.107), which
coincides with other authors ﬁndings [5,13,20–24] who
reported better oncologic outcome for SSR. Alternatively,
other researchers [25,26] also reported that the type of
resection (AR versus APR) did not inﬂuence the risk of local
recurrence in lower rectal cancer if surgery was optimized. In
general, the evidence appears to suggest that local recurrence
is a reﬂection of the initial tumor biology (stage, histologic
grade, and lymphovascular invasion) rather than the type
of operative procedure initially performed [27,28]. Neverthe-
less, one should not overlook the possible impact of the small
size of this study sample, and relative short duration of
follow up.In this study, with both groups of patients having compara-
ble clinical, demographic and pathologic criteria, this study
reports a 3 year OS, between patients in whom the sphincter
was preserved compared to those who underwent APR, of
85.4% and 84.9%, respectively, which are comparable to other
studies [13,15,24,29] who reported a 5 years overall survival of
65.8–82%, and 52.3–62.9%, respectively, likely reﬂecting
patient, biologic, and treatment-related factors [15], this also
supports the reported improvement of OS with sphincter
preservation following preoperative chemoradiation [30].
Since, the choice between the different techniques of SSR
was based, not only on the conventional distance between
the tumor and the anal verge, or the anorectal ring, but also
by inﬁltration or not of the internal anal sphincter, as well as
the by the presence of other tumors within the rest of the
colon, we were not capable to recruit relatively equal numbers
of patients from each technique group; consequently, we could
not evaluate, statistically, the results of the separate sphincter
preservation techniques.
Regarding the impact of the different levels of low rectal
tumors on local recurrence, Rulier et al. [31] classiﬁed patients
with low rectal cancer (<6 cm from anal verge) into 4 types:
type I (supra-anal tumors: >1 cm from anal ring) and these
had coloanal anastomosis, type II (juxta-anal tumors: <1 cm
from anal ring) and they had partial intersphincteric resection,
type III (intra-anal tumors: internal anal sphincter invasion)
and these had total intersphincteric resection, and type IV
(transanal tumors: external anal sphincter invasion) and they
had abdominoperineal resection. They reported no difference
in local recurrence (5–9% vs 6%), distant recurrence (23%
vs 23%), and disease-free survival (70–73% vs 68%) at 5 years
between ultra-low (types II–III) and conventional (type I)
sphincter-preserving surgery. Predictive factors of survival
were tumor stage and CRM-negative but not the type of tumor
or type of surgery [15,31].
The short period of 3 years follow-up time may have given
potential for detection and follow-up time bias for the
identiﬁcation of local recurrences that may have been delayed
by use of adjuvant radiation. The relatively small number of
surgeons allowed for standardization of technique and surgical
quality control.
According to Kirwan et al. [32], the present study
demonstrates, that SSR showed, at 12 month postoperatively,
a perfect (Grade V) functional outcome in 72.1%, and gas
incontinence (Grade IV) in 19.7%, comparable to other studies
reporting 64.3% and 14.2%, respectively [2]. Only 8.2% of
patients experienced major fecal leak (Grade II), especially at
night.Conclusion
In low rectal cancer, the sphincter preservation appears to
have nearly the same oncologic outcome compared to
APR, this might be attributed to the small sample size
and short follow up period. It might also be due to the
impact of the initial tumor biology (stage, histologic grade,
and lymphovascular invasion) which was not tackled in this
study. However, patients with sphincter preservation have
certainly demonstrated an indisputable better functional
outcome, in terms of stoma avoidance and adequate
continence.
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